Last $71.43 USD
Change Today +0.50 / 0.70%
Volume 5.1M
ESRX On Other Exchanges
Symbol
Exchange
ESRX is not on other exchanges.
As of 8:10 PM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

express scripts holding co (ESRX) Snapshot

Open
$71.11
Previous Close
$70.93
Day High
$71.94
Day Low
$70.92
52 Week High
03/11/14 - $79.37
52 Week Low
04/25/13 - $56.68
Market Cap
55.4B
Average Volume 10 Days
5.6M
EPS TTM
$2.87
Shares Outstanding
775.5M
EX-Date
--
P/E TM
24.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for EXPRESS SCRIPTS HOLDING CO (ESRX)

express scripts holding co (ESRX) Related Businessweek News

View More BusinessWeek News

express scripts holding co (ESRX) Details

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. It operates in two segments, PBM and Other Business Operations. The company’s PBM services comprise retail network pharmacy administration; home delivery pharmacy; benefit design consultation; drug utilization review; drug formulary management; clinical solutions to improve health outcomes; an array of Medicare Part D, Medicaid, and health insurance marketplace; specialty pharmacy services, such as the distribution of fertility pharmaceuticals that require special handling or packaging; bio- pharmaceutical services, including reimbursement and logistics solutions; group purchasing organization administration; and consumer health and drug information services. It is also involved in the distribution of pharmaceuticals and medical supplies to providers and clinics; development of scientific evidence to guide the use of medicines; and provision of case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. Express Scripts Holding Company provides its PBM services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans, and government health programs; and specialty services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.

29,975 Employees
Last Reported Date: 02/20/14
Founded in 1986

express scripts holding co (ESRX) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.2M
Executive Vice President and General Counsel
Total Annual Compensation: $617.8K
Vice President and Corporate Treasurer
Total Annual Compensation: $486.2K
Executive Vice President of Sales and Marketi...
Total Annual Compensation: $689.6K
Compensation as of Fiscal Year 2013.

express scripts holding co (ESRX) Key Developments

Express Scripts Wins 7-Year TRICARE Pharmacy Program Contract

The U.S. Department of Defense awarded Express Scripts administration of the TRICARE Pharmacy Program, Fourth Generation (TPharm4) contract serving approximately 10 million beneficiaries. The seven-year contract will include administering a retail pharmacy network, operating the TRICARE Mail Order Pharmacy and providing specialty pharmacy services effective May 1, 2015. Express Scripts has been providing the DoD's home delivery and retail pharmacy network services since 2003 and 2004, respectively, adding specialty pharmacy in 2009. Express Scripts' technical and administrative services will expand under the TPharm4 contract, as the company will serve the pharmacy needs of the military worldwide, including Military Treatment Facilities. Express Scripts has achieved beneficiary satisfaction ratings as high as 98.3%, while consistently delivering significant savings for the DoD through cost-containment strategies such as increasing home delivery, driving deep retail network discounts and administering advanced clinical programs with specialist pharmacists.

Express Scripts Mulls Acquisitions

Express Scripts Holding Company (NasdaqGS:ESRX) announced its earnings results for quarter 4, 2013. Cathy Smith, Chief Financial Officer said, "First and foremost our highest returning investment will always be in organic growth. This next year we expect to grow -- expect to spend -- between $400 million and $450 million in CapEx, pretty consistent with last year. Our second priority for capital investment, or capital allocation, will be strategic acquisitions."

Express Scripts Holding Co. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013; Provides Earnings Guidance for the First Quarter and Full Year for the Fiscal Year Ending December 31, 2014

Express Scripts Holding Co. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company reported revenues of $25,781.4 million against $27,365.1 million a year ago. Operating income was $828.8 million against $906.9 million a year ago. Income before income taxes was $726.3 million against $759.6 million a year ago. Net income attributable to the parent company was $501.9 million against $504.1 million a year ago. Diluted earnings per share from continuing operations attributable to the parent company were $0.64 against $0.62 a year ago. Adjusted EBITDA from continuing operations attributable to the company was $1,668.3 million against $1,648.2 million a year ago. For the year, the company reported revenues of $104,098.8 million against $93,714.3 million a year ago. Operating income was $3,551.7 million against $2,793.9 million a year ago. Income before income taxes was $3,030.3 million against $2,200.4 million a year ago. Net income attributable to the parent company was $1,844.6 million against $1,312.9 million a year ago. Diluted earnings per share from continuing operations attributable to the parent company were $2.31 against $1.80 a year ago. Net cash provided by operating activities from continuing operations was $4,768.9 million against $4,751.1 million a year ago. Purchases of property and equipment were $423.0 million against $160.2 million a year ago. Adjusted EBITDA from continuing operations attributable to the company was $6,664.2 million against $5,403.2 million a year ago. The company provided earnings guidance for the year ending December 31, 2014. For the year, the company expects adjusted EPS from continuing operations attributable to the company of $4.88 to $5.00. Depreciation is expected to be $400 million to $420 million. Effective income tax rate on continuing operations is expected to be 38.0% to 38.5%. Adjusted EBITDA is expected to be in the range of $6,850 million to $7,050 million. Adjusted EBITDA from continuing operations attributable to Express Scripts per adjusted claim are expects to be in the range of $5.15 to $5.25. Cash flow from continuing operations expected to be $4,700 million to $5,300 million. Capital expenditures expected to be $400 million to $450 million. For the first quarter, the company’s adjusted earnings per diluted share from continuing operations attributable to the company is expected to be between $0.98 and $1.02, up 7% to 11% from the first quarter of 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ESRX:US $71.43 USD +0.50

ESRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $68.61 USD -0.34
McKesson Corp $170.46 USD -0.17
Kroger Co/The $45.35 USD -0.10
UnitedHealth Group Inc $76.59 USD +1.26
Walgreen Co $67.42 USD +0.03
View Industry Companies
 

Industry Analysis

ESRX

Industry Average

Valuation ESRX Industry Range
Price/Earnings 30.7x
Price/Sales 0.5x
Price/Book 2.5x
Price/Cash Flow 14.7x
TEV/Sales 0.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXPRESS SCRIPTS HOLDING CO, please visit www.express-scripts.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.